Urolithiasis
Conditions
Interventions
Drug withdrawal group:The drugs were stopped for 5-7 days during the perioperative period, and low molecular weight heparin was bridged or not bridged
Continuous treatment group:Continuous medication during perioperative period
Sponsors
Shanghai General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Patients with urinary calculi undergoing rigid ureteroscopic and soft ureteroscopic lithotripsy; 2. Normal renal function; 3. Aged 18-70 years; 4. Taking antiplatelet drugs regularly (antiplatelet drug group), e.g., Clopidogrel, Aspirin, Ticagrelor, Dipyridamole, Cilostazol, Indobufen; 5. Taking anticoagulant drugs regularly (anticoagulant group), e.g., Warfarin, Dabigatran, Rivaroxaban, Edoxaban.
Exclusion criteria
Exclusion criteria: 1. Solitary kidney; 2. Previous history of renal transplantation or urinary tract diversion; 3. Pongenital malformation of urinary system; 4. Abnormal coagulation mechanism due to blood system disease, liver disease, etc.; 5. Severe heart or lung disease, malignant tumor and immunodeficiency.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| blood routine;Operation time;The postoperative complications;Stone clearance rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| height;weight;age; | — |
Countries
China
Contacts
Public ContactYi Shao
Shanghai General Hospital
Outcome results
None listed